Follow
Roser Lopez-Alemany
Roser Lopez-Alemany
Investigador asociado, IDIBELL
Verified email at idibell.cat
Title
Cited by
Cited by
Year
α-Enolase, a Multifunctional Protein: Its Role on Pathophysiological Situations
À Díaz-Ramos, A Roig-Borrellas, A García-Melero, R López-Alemany
BioMed Research International 2012, 2012
4322012
Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against α‐Enolase
R López‐Alemany, C Longstaff, S Hawley, M Mirshahi, P Fábregas, ...
American journal of hematology 72 (4), 234-242, 2003
1492003
Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo
M Suelves, R López-Alemany, F Lluıs, G Aniorte, E Serrano, M Parra, ...
Blood, The Journal of the American Society of Hematology 99 (8), 2835-2844, 2002
1282002
Plasminogen activator inhibitor type‐1 inhibits insulin signaling by competing with αvβ3 integrin for vitronectin binding
R López‐Alemany, JM Redondo, Y Nagamine, P Muñoz‐Cánoves
European Journal of Biochemistry 270 (5), 814-821, 2003
932003
uPA deficiency exacerbates muscular dystrophy in MDX mice
M Suelves, B Vidal, AL Serrano, M Tjwa, J Roma, R López-Alemany, ...
The Journal of cell biology 178 (6), 1039-1051, 2007
912007
Identification of an epitope of α-enolase (a candidate plasminogen receptor) by phage display
B Arza, J Félez, R Lopez-Alemany, LA Miles, P Munñoz-Cánoves
Thrombosis and haemostasis 78 (09), 1097-1103, 1997
681997
Purification of the plasmin receptor from human carcinoma cells and comparison to α-enolase
R Lopez-Alemany, P Correc, L Camoin, P Burtin
Thrombosis research 75 (4), 371-381, 1994
661994
Plasmin generation dependent on α-enolase-type plasminogen receptor is required for myogenesis
R López-Alemany, M Suelves, P Muñoz-Cánoves
Thrombosis and haemostasis 90 (10), 724-733, 2003
592003
Alpha-enolase plasminogen receptor in myogenesis
R Lopez-Alemany, M Suelves, A Diaz-Ramos, B Vidal, P Munoz-Canoves
Front Biosci 10 (1), 30-36, 2005
542005
The plasminogen activation system in skeletal muscle regeneration: antagonistic roles of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1)
M Suelves, B Vidal, V Ruiz, B Baeza-Raja, A Diaz-Ramos, I Cuartas, ...
Front Biosci 10, 2978-2985, 2005
512005
Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway
L Lagares-Tena, S García-Monclús, R López-Alemany, ...
Oncotarget 7 (35), 56889, 2016
472016
EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma
S Garcia‐Monclús, R López‐Alemany, O Almacellas‐Rabaiget, ...
International journal of cancer 143 (5), 1188-1201, 2018
432018
Plasmin-mediated release of the guidance molecule F-spondin from the extracellular matrix
V Tzarfaty-Majar, R López-Alemany, Y Feinstein, L Gombau, ...
Journal of Biological Chemistry 276 (30), 28233-28241, 2001
422001
DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1
J Huertas-Martínez, F Court, S Rello-Varona, D Herrero-Martin, ...
Cancer letters 386, 196-207, 2017
302017
“(Not) all (dead) things share the same breath”: identification of cell death mechanisms in anticancer therapy
S Rello-Varona, D Herrero-Martín, R López-Alemany, C Munoz-Pinedo, ...
Cancer Research 75 (6), 913-917, 2015
262015
Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth
J Huertas-Martínez, S Rello-Varona, D Herrero-Martín, I Barrau, ...
Oncotarget 5 (20), 9744, 2014
232014
Requirement of plasminogen binding to its cell-surface receptor α-enolase for efficient regeneration of normal and dystrophic skeletal muscle
À Díaz-Ramos, A Roig-Borrellas, A García-Melero, A Llorens, ...
PLoS One 7 (12), e50477, 2012
212012
LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity
O Almacellas-Rabaiget, P Monaco, J Huertas-Martinez, S García-Monclús, ...
Cancer Letters 474, 1-14, 2020
202020
Comparative localization of receptors for plasmin and for urokinase on MCF7 cells
S Zhang, M Laurent, R Lopez-Alemany, A Mazar, J Henkin, E Ronne, ...
Experimental cell research 207 (2), 290-299, 1993
171993
The importance of being dead: cell death mechanisms assessment in anti-sarcoma therapy
S Rello-Varona, D Herrero-Martín, L Lagares-Tena, R López-Alemany, ...
Frontiers in Oncology 5, 82, 2015
162015
The system can't perform the operation now. Try again later.
Articles 1–20